Disopan Tablet 2mg

Disopan

Clonazepam

5 Each saber contains Onerepem USPOS tablet contains Capa USP Each label contains Clonerpar

Lennox-Gastaut syndrome

Description

1: Panic attack

2. Eplepey

Status epilepticus

Indications

infantile spesm Absence seizure

•Myocone ure

Up to 1 year 0.25 mg daily in divided dose.

increase gradually to 0.5-1 mg 1-5 years 0.25 mg daily in divided dose.

Increase to 1-3 mg 5-12 year 05 mg dally in divided dose

increase to 3-6mg

Anetic and alone seu Partar seizure

Dosage and administration

Infants and children

Initial dose: 0.01-0.03 mogiday not to exceed 0.05 mg/kg/day

increment dose not more than 0.25-0.5 mg at intervals of 3 days

Maintenance dose 01-02 mg/kg/day Dosing interval bid./Lid

Adults and elderly

Intial dose mg daily in divided dose Ederly 0.5 mg), not to exceed 1.5 mg/day

initial dose should be low and increased gradually to a mainten e dose that controls seizure without toxic effects. During discontinuation

the dose should be tapered

The most frequently occurring side effects of clonazepam are referable to CNS depression, drowsiness, fatigue, dizziness, muse hypotonia, co-ordination disturbance, hypersalivation in infants, paradoxical aggression, iritability and mental change

Chemically, clonazepam is a benzodarepne dervative echins several pharmacogic properties which benzodiazepine class of drugs in human is cate of suppressing the spike and wave dhege absence seizure (petit decreasing the frequency, amplitude, duration and spread of discharge in miner motor

are characteristics of th

mal) and

3. Boar affective de 4 Duceyskinesia

5. Choreo m

6 Fulgurant pain

7 Tourette's syndrome

aflesistant depression

9 Noctural myoclonus 10 Trigeminal neura

Manufactured by

Incepta Incepta Pharmaceuticals Ltd

Savar, Dhaka, Bangladesh

Registered Trademark